1.
|
Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 12-079, NCT01606787
|
|
2.
|
Phase: Phase II, Phase I Type: Supportive care, Treatment Status: Active Age: 18 to 75 Sponsor: NCI, Other Protocol IDs: OHSU-2868, P30CA069533, 8507, SOL-04058-L, 2868, OHSU-8507, OHSU-SOL-04058-L, NCT00303849
|
|
3.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 to 75 Sponsor: NCI, Other Protocol IDs: OHSU-1012, 3R01CA137488, 1012, SOL-05025-L, OHSU-SOL-05025-L, NCT00293475
|
|
4.
|
Phase: Phase II, Phase I Type: Supportive care, Treatment Status: Approved-not yet active Age: 18 to 75 Sponsor: NCI, Other Protocol IDs: OHSU-2188, 2188, SOL-06015, OHSU-SOL-06015, NCT00397501
|
|
5.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 1 to 30 Sponsor: Other Protocol IDs: OHSU-5056, SOL-08131-L, NCT00983398
|
|
6.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 1001010839, NCT01269853
|
|
7.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Tissue collection/Repository, Treatment Status: Active Age: 45 to 75 Sponsor: Other Protocol IDs: CDR0000687653, CRUK-PH1/093, EUDRACT-2004-002413-37, NCT01233492
|